Myra has a broad corporate practice specialising in mergers & acquisitions, public takeovers, IPOs, capital market transactions and corporate restructurings. She advises companies and boards of directors on corporate governance and strategic issues.
Significant transactions include advising:
- Clayton, Dubilier & Rice on its recommended takeover of UDG Healthcare plc
- Amgen Inc, on its recommended takeover of Horizon Therapeutics plc
- Sale of Cpl Resources plc to Japanese publicly listed company, Outsourcing Inc
- Fenergo on its sale to Bridgepoint Advisers Limited, Astorg Asset Management S.à.r.l. and the management team
- FINEOS Corporation Holding plc on its IPO on the Australian Securities Exchange
- The Irish Times DAC on its acquisition of RIP.ie
- The sellers of Beacon Hospital to Macquarie Asset Management
- Skillsoft Group on its restructuring through US Chapter 11 proceedings.
Myra is on the Management Board of the International Bar Association, ‘the Global voice of the Legal Profession’. She is a Board member of the National Treasury Management Agency. In October 2024, Myra was granted Patents of Precedence by the Supreme Court of Ireland, conferring the right to use the title of Senior Counsel.
2025 Chambers Global
"It is always a pleasure to work with Myra Garrett."

2025 Chambers Europe 2024
"She is very experienced, commercial and solution-focused."

2024 IFLR 1000
Myra is ranked as a Market Leader in IFLR 1000 and ranked as Women Leaders – the elite cohort of the leading female transactional experts in local markets globally.

2023 Who's Who Legal
Myra is recommended as a Global Leader in M&A for WWL 2023.
2023 Chambers Global
“Myra Garrett is a very strong leader, with deep expertise, commercial awareness and an incredible ability to both be engaged in the detail and command the bigger picture.” “She is an excellent lawyer who mixes legal and market knowledge with great client handling skills.”
